These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 36851109)

  • 1. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study.
    Aldali J; Meo SA; Al-Khlaiwi T
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
    Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects associated with homogenous and heterogenous doses of Oxford-AstraZeneca vaccine among adults in Bangladesh: an observational study.
    Sharif N; Opu RR; Saha T; Khan A; Aljohani A; Alsuwat MA; García CO; Vázquez AA; Alzahrani KJ; Miramontes-González JP; Dey SK
    Sci Rep; 2024 Oct; 14(1):23794. PubMed ID: 39394252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.
    Meo SA; Shaikh N; Abukhalaf FA; Meo AS
    Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile.
    Alzarea AI; Khan YH; Alatawi AD; Alanazi AS; Alzarea SI; Butt MH; Almalki ZS; Alahmari AK; Mallhi TH
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Post-Vaccination Symptoms of Two Common COVID-19 Vaccines Used in Abha, Aseer Region, Kingdom of Saudi Arabia.
    Adam M; Gameraddin M; Alelyani M; Alshahrani MY; Gareeballah A; Ahmad I; Azzawi A; Komit B; Musa A
    Patient Prefer Adherence; 2021; 15():1963-1970. PubMed ID: 34522089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.
    Tobaiqy M; MacLure K; Elkout H; Stewart D
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the Side Effects of Pfizer and Oxford COVID-19 Vaccines in the Eastern Province of Saudi Arabia.
    Farhat M; Al-Ibrahim R; Almohammedali A; Aljishi R; Alalwan B
    Int J Gen Med; 2022; 15():7547-7558. PubMed ID: 36196371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees.
    Alghamdi AN; Alotaibi MI; Alqahtani AS; Al Aboud D; Abdel-Moneim AS
    Front Med (Lausanne); 2021; 8():760047. PubMed ID: 34692740
    [No Abstract]   [Full Text] [Related]  

  • 12. Pattern of self-reported adverse events related to COVID-19 vaccines in Saudi Arabia: A nationwide study.
    Alkhalifah JM; Al Seraihi A; Al-Tawfiq JA; Alshehri BF; Alhaluli AH; Alsulais NM; Alessa MM; Seddiq W; Aljeri T; Qahtani MH; Barry M; Al-Otaiby M
    Front Public Health; 2023; 11():1043696. PubMed ID: 36908451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events following administration of COVID-19 vaccines in Saudi Arabia.
    Alqahtani S; Jokhdar H; Al-Tawfiq JA; Al-Otaibi S; Assiri A; Almudarra S; Alabdulkareem K; Haji A
    Sci Rep; 2022 Nov; 12(1):19551. PubMed ID: 36379996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom.
    Otero-Losada M; Petrovsky N; Alami A; Crispo JA; Mattison D; Capani F; Goetz C; Krewski D; Perez-Lloret S
    Expert Opin Drug Saf; 2023 Apr; 22(4):343-349. PubMed ID: 36043937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia.
    Alhazmi A; Alamer E; Daws D; Hakami M; Darraj M; Abdelwahab S; Maghfuri A; Algaissi A
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34207394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing COVID-19 Vaccination Side Effects Among the Adult Population in Jeddah, Saudi Arabia.
    Alamri T; Anwer F; Butt NS; Alganmi AH; Alotaibi SA; Alzibali KF; Hawsawi HA; Bakarman M; Malik AA
    Cureus; 2023 Oct; 15(10):e47136. PubMed ID: 37854474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study.
    Bernardi FF; Mascolo A; Sarno M; Capoluongo N; Trama U; Ruggiero R; Sportiello L; Fusco GM; Bisogno M; Coscioni E; Iervolino A; Di Micco P; Capuano A; Perrella A
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Adverse Events Associated with Three Doses of the COVID-19 Vaccination in Adults in the Western Region of Saudi Arabia: A Cross-Sectional Study.
    Aldali HJ; Aldali JA; Alotaibi BA; Alasiri GA; Alromih AM; Elsokkary EM; Aldali AZ; Almeziny A
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum.
    Kaura A; Trickey A; Shah ASV; Benedetto U; Glampson B; Mulla A; Mercuri L; Gautama S; Costelloe CE; Goodman I; Redhead J; Saravanakumar K; Mayer E; Mayet J
    EClinicalMedicine; 2022 Apr; 46():101344. PubMed ID: 35295900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.